These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 22675463)

  • 1. Fundamentals of FGF19 & FGF21 action in vitro and in vivo.
    Adams AC; Coskun T; Rovira AR; Schneider MA; Raches DW; Micanovic R; Bina HA; Dunbar JD; Kharitonenkov A
    PLoS One; 2012; 7(5):e38438. PubMed ID: 22675463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity.
    Agrawal A; Parlee S; Perez-Tilve D; Li P; Pan J; Mroz PA; Kruse Hansen AM; Andersen B; Finan B; Kharitonenkov A; DiMarchi RD
    Mol Metab; 2018 Jul; 13():45-55. PubMed ID: 29789271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential specificity of endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in complex with KLB.
    Yang C; Jin C; Li X; Wang F; McKeehan WL; Luo Y
    PLoS One; 2012; 7(3):e33870. PubMed ID: 22442730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21.
    Kurosu H; Choi M; Ogawa Y; Dickson AS; Goetz R; Eliseenkova AV; Mohammadi M; Rosenblatt KP; Kliewer SA; Kuro-O M
    J Biol Chem; 2007 Sep; 282(37):26687-26695. PubMed ID: 17623664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FGF19 regulates cell proliferation, glucose and bile acid metabolism via FGFR4-dependent and independent pathways.
    Wu AL; Coulter S; Liddle C; Wong A; Eastham-Anderson J; French DM; Peterson AS; Sonoda J
    PLoS One; 2011 Mar; 6(3):e17868. PubMed ID: 21437243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice.
    Wu X; Ge H; Lemon B; Weiszmann J; Gupte J; Hawkins N; Li X; Tang J; Lindberg R; Li Y
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14379-84. PubMed ID: 19706524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGF19-induced hepatocyte proliferation is mediated through FGFR4 activation.
    Wu X; Ge H; Lemon B; Vonderfecht S; Weiszmann J; Hecht R; Gupte J; Hager T; Wang Z; Lindberg R; Li Y
    J Biol Chem; 2010 Feb; 285(8):5165-70. PubMed ID: 20018895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A unique FGF23 with the ability to activate FGFR signaling through both αKlotho and βKlotho.
    Wu X; Weiszmann J; Ge H; Baribault H; Stevens J; Hawkins N; Vonderfecht S; Gardner J; Gupte J; Sheng J; Wang M; Li Y
    J Mol Biol; 2012 Apr; 418(1-2):82-9. PubMed ID: 22370560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential receptor selectivity of the FGF15/FGF19 orthologues determines distinct metabolic activities in
    Hansen AMK; Vienberg SG; Lykkegaard K; Zhao X; Tingqing G; Han D; Zhang X; Thøgersen H; Sass-Ørum K; Tagmose T; Raun K; Andersen B
    Biochem J; 2018 Sep; 475(18):2985-2996. PubMed ID: 30127091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curtailing FGF19's mitogenicity by suppressing its receptor dimerization ability.
    Niu J; Zhao J; Wu J; Qiao G; Gu J; Zhou C; Li Q; Ying L; Wang D; Lin H; Li X; Mohammadi M; Huang Z
    Proc Natl Acad Sci U S A; 2020 Nov; 117(46):29025-29034. PubMed ID: 33144503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-1β inhibits β-Klotho expression and FGF19 signaling in hepatocytes.
    Zhao Y; Meng C; Wang Y; Huang H; Liu W; Zhang JF; Zhao H; Feng B; Leung PS; Xia Y
    Am J Physiol Endocrinol Metab; 2016 Feb; 310(4):E289-300. PubMed ID: 26670488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGF19, FGF21, and an FGFR1/β-Klotho-Activating Antibody Act on the Nervous System to Regulate Body Weight and Glycemia.
    Lan T; Morgan DA; Rahmouni K; Sonoda J; Fu X; Burgess SC; Holland WL; Kliewer SA; Mangelsdorf DJ
    Cell Metab; 2017 Nov; 26(5):709-718.e3. PubMed ID: 28988823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-terminal tail of FGF19 determines its specificity toward Klotho co-receptors.
    Wu X; Lemon B; Li X; Gupte J; Weiszmann J; Stevens J; Hawkins N; Shen W; Lindberg R; Chen JL; Tian H; Li Y
    J Biol Chem; 2008 Nov; 283(48):33304-9. PubMed ID: 18829467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance.
    Hale C; Chen MM; Stanislaus S; Chinookoswong N; Hager T; Wang M; Véniant MM; Xu J
    Endocrinology; 2012 Jan; 153(1):69-80. PubMed ID: 22067317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual actions of fibroblast growth factor 19 on lipid metabolism.
    Wu X; Ge H; Baribault H; Gupte J; Weiszmann J; Lemon B; Gardner J; Fordstrom P; Tang J; Zhou M; Wang M; Li Y
    J Lipid Res; 2013 Feb; 54(2):325-32. PubMed ID: 23204296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF21 acts as a negative regulator of bile acid synthesis.
    Chen MM; Hale C; Stanislaus S; Xu J; Véniant MM
    J Endocrinol; 2018 May; 237(2):139-152. PubMed ID: 29615519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients.
    Gallego-Escuredo JM; Gómez-Ambrosi J; Catalan V; Domingo P; Giralt M; Frühbeck G; Villarroya F
    Int J Obes (Lond); 2015 Jan; 39(1):121-9. PubMed ID: 24813368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGF21 requires βklotho to act in vivo.
    Adams AC; Cheng CC; Coskun T; Kharitonenkov A
    PLoS One; 2012; 7(11):e49977. PubMed ID: 23209629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF19 and FGF21 for the Treatment of NASH-Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human.
    Henriksson E; Andersen B
    Front Endocrinol (Lausanne); 2020; 11():601349. PubMed ID: 33414764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-34a and Impaired FGF19/21 Signaling in Obesity.
    Fu T; Kemper JK
    Vitam Horm; 2016; 101():175-96. PubMed ID: 27125742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.